Skip to search formSkip to main contentSkip to account menu

JNK Mitogen-Activated Protein Kinases

Known as: c-jun N-Terminal Kinase, JNK Mitogen-Activated Protein Kinases [Chemical/Ingredient], jun NH2 Terminal Kinase 
A subgroup of mitogen-activated protein kinases that activate TRANSCRIPTION FACTOR AP-1 via the phosphorylation of C-JUN PROTEINS. They are… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Background: The cerebellum neuronal apoptosis cell is characteristic lesions of heroin spongiform leukoencephalopathy (HSLE), and… 
2016
2016
Background The AP-1 transcription factor c-Jun is a key downstream target of c-Jun N-terminal kinase (JNK) which mediates… 
2015
2015
OBJECTIVE To explore whether edaravone protects cells damage via mitogen-activated protein kinases (MAPKs) signal pathway, and… 
2011
2011
c-Jun N-terminal kinase-3 (JNK-3) has been shown to mediate neuronal apoptosis and make the promising therapeutic target for… 
2009
2009
In this study, we describe a novel function of the p34 protein, which is both an oncogenic protein and a positive regulator of… 
2007
2007
Protein kinase CA (PKCA) has been suggested to play an important role in tumorigenesis, invasion, and metastasis. In this study… 
2003
2003
Sajid, M., R. Zhao, A. Pathak, S. S. Smyth, and G. A. Stouffer. v 3-Integrin antagonists inhibit thrombin-induced proliferation… 
2001
2001
Gliomas are the most common primary intracranial tumors. One extracellular matrix component that has been implicated in glial…